A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 3,821,997 shares of MRK stock, worth $372 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
3,821,997
Previous 3,530,448 8.26%
Holding current value
$372 Million
Previous $437 Million 0.7%
% of portfolio
0.47%
Previous 0.54%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $32.4 Million - $37.6 Million
291,549 Added 8.26%
3,821,997 $434 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $46 Million - $49.4 Million
371,348 Added 11.75%
3,530,448 $437 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $56.6 Million - $66 Million
500,159 Added 18.81%
3,159,100 $417 Million
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $18.6 Million - $20.2 Million
185,310 Added 7.49%
2,658,941 $290 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $18.9 Million - $21 Million
183,345 Added 8.01%
2,473,631 $255 Million
Q2 2023

Aug 09, 2023

BUY
$108.61 - $118.38 $18.1 Million - $19.7 Million
166,539 Added 7.84%
2,290,286 $264 Million
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $20.8 Million - $23.2 Million
201,969 Added 10.51%
2,123,747 $226 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $18.3 Million - $23.4 Million
208,995 Added 12.2%
1,921,778 $213 Million
Q3 2022

Nov 01, 2022

BUY
$84.53 - $94.96 $13.5 Million - $15.2 Million
159,632 Added 10.28%
1,712,783 $148 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $10 Million - $11.4 Million
120,256 Added 8.39%
1,553,151 $142 Million
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $8.74 Million - $9.79 Million
118,869 Added 9.05%
1,432,895 $118 Million
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $12.1 Million - $15.2 Million
167,387 Added 14.6%
1,314,026 $101 Million
Q3 2021

Nov 04, 2021

BUY
$71.68 - $78.83 $7.65 Million - $8.41 Million
106,715 Added 10.26%
1,146,639 $86.1 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $8.57 Million - $9.48 Million
121,903 Added 13.28%
1,039,924 $80.9 Million
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $6.31 Million - $7.43 Million
91,660 Added 11.09%
918,021 $70.8 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $2.05 Million - $2.28 Million
28,602 Added 3.59%
826,361 $67.6 Million
Q3 2020

Nov 10, 2020

SELL
$73.18 - $82.95 $1.09 Million - $1.24 Million
-14,949 Reduced 1.84%
797,759 $66.2 Million
Q2 2020

Aug 06, 2020

BUY
$70.42 - $80.13 $7.23 Million - $8.23 Million
102,662 Added 14.46%
812,708 $62.8 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $1.08 Million - $1.5 Million
-17,123 Reduced 2.35%
710,046 $54.6 Million
Q4 2019

Feb 05, 2020

BUY
$77.58 - $87.54 $9.26 Million - $10.4 Million
119,317 Added 19.63%
727,169 $66.4 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $291,234 - $317,456
-3,828 Reduced 0.63%
607,852 $51.2 Million
Q2 2019

Aug 08, 2019

BUY
$69.84 - $81.59 $14.9 Million - $17.4 Million
213,041 Added 53.44%
611,680 $51.3 Million
Q1 2019

Apr 26, 2019

BUY
$69.58 - $79.36 $1.25 Million - $1.43 Million
18,022 Added 4.73%
398,639 $33.2 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $6.45 Million - $7.48 Million
-98,816 Reduced 20.61%
380,617 $28.2 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $625,648 - $735,724
-10,845 Reduced 2.21%
479,433 $34 Million
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $159,657 - $187,580
-3,141 Reduced 0.64%
490,278 $29.8 Million
Q1 2018

May 02, 2018

SELL
$50.96 - $59.23 $1.72 Million - $2 Million
-33,833 Reduced 6.42%
493,419 $26.9 Million
Q4 2017

Feb 06, 2018

BUY
$51.62 - $61.64 $302,493 - $361,210
5,860 Added 1.12%
527,252 $29.6 Million
Q3 2017

Nov 01, 2017

BUY
$58.67 - $63.13 $30.6 Million - $32.9 Million
521,392
521,392 $33.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.